All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Shop and compare

Weight Loss

GLP-1 weight-loss programs — semaglutide and tirzepatide, reviewed online by a licensed provider.

7

Products

0

Blends

6

Shoppable

FormBlends product finder

Browsing

Semaglutide vs Tirzepatide

Provider-reviewed

Licensed 503A pharmacy

Shop first

Browse Weight Loss

Products are shown first. Research, mechanism notes, comparisons, and decision support stay below the shopping surface.

Showing 7 of 99
Most PopularAssessmentCompounded Semaglutide GLP-1 Weight Loss program visual summary
GLP-1 Weight Loss$99

Compounded Semaglutide

The gold standard in GLP-1 weight management

Up to 14.9% mean lossSTEP 1 evidence
Start Free Assessment
Strongest ResultsAssessmentCompounded Tirzepatide GLP-1 Weight Loss program visual summary
GLP-1 Weight Loss$349

Compounded Tirzepatide

Dual-action GIP/GLP-1 for maximum results

Up to 22.5% mean lossSURMOUNT evidence
Start Free Assessment
Best ValueAssessmentLiraglutide GLP-1 Weight Loss program visual summary
GLP-1 Weight Loss$199

Liraglutide

The proven GLP-1 pioneer with years of clinical data

Daily GLP-1 optionLong safety history
Start Free Assessment
Coming SoonComing SoonOral Semaglutide Drops GLP-1 Weight Loss program visual summary
GLP-1 Weight Lossfrom $249

Oral Semaglutide Drops

A non-injectable semaglutide option in sublingual drop form — starter and maintenance doses available.

Weight lossClinical trial backed
Join waitlist
Coming SoonComing SoonSublingual GLP-1 (RDT) GLP-1 Weight Loss program visual summary
GLP-1 Weight Lossfrom $249

Sublingual GLP-1 (RDT)

Rapid-dissolve GLP-1 tablets in semaglutide or tirzepatide — a needle-free alternative for medically supervised weight management.

Weight lossClinical trial backed
Join waitlist
Coming SoonComing SoonLiraglutide (Daily GLP-1) GLP-1 Weight Loss program visual summary
GLP-1 Weight Lossfrom $399

Liraglutide (Daily GLP-1)

A daily injectable GLP-1 option for medically supervised weight management — prescribed after an online provider review.

Weight lossClinical trial backed
Join waitlist
Triple AgonistComing SoonRetatrutide GLP-1 Weight Loss research profile visual summary
GLP-1 Weight Lossfrom $389

Retatrutide

6mg vial

Triple-agonist: GLP-1, GIP, and glucagon receptor activation

Weight lossClinical trial backed
Join waitlist

Source reviewed

How to compare product options

FormBlends medical team | May 29, 2026

Shoppers comparing FormBlends GLP-1 programs, peptide bundles, and research profiles need a direct answer on fit first, then the evidence, timeline, and provider-review details that change the decision.

Answer who qualifies, what it costs, what forms exist, common side effects, and which alternatives to compare.

Put the practical answer near the top before the commercial call to action.

Link to dosing, safety, cost, and comparison guides that support the decision.

compare GLP-1 programs and peptides page visual summary
Visual summary for compare GLP-1 programs and peptides and the main search intent on this page.

Questions this page should answer clearly

How do I choose between FormBlends GLP-1 programs and peptide bundles?
Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
Which FormBlends products can I add to cart versus which require provider review?
Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
How do semaglutide and tirzepatide programs compare on results and timeline?
Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
What evidence and safety review backs each FormBlends product?
Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.

Finder facts for search and AI answers

What this product finder answers

Catalog scope

7 weight loss profiles

GLP-1 weight-loss programs — semaglutide and tirzepatide, reviewed online by a licensed provider.

Clinical access

6 GLP-1 program profiles in this view

GLP-1 treatment paths require licensed-provider review for eligibility, contraindications, dosing, and side-effect management.

Research status

0 watchlist or research-only profiles in this view

Research/watchlist pages should not be treated as ordinary patient access pages.

Decision role

Compare goal fit, evidence strength, mechanism, timeline, and next step

The finder should route users into the right product page rather than making every product look equivalent.